Singing and COPD: a pilot randomised controlled trial

Not Applicable

Completed

• Conditions: Chronic obstructive pulmonary disease (COPD); Respiratory; Chronic obstructive pulmonary disease

• Registration Number: ISRCTN42943709
• Lead Sponsor: Canterbury Christ Church University

Brief Summary

2022 Results article in https://storage.googleapis.com/wzukusers/user-20563976/documents/77ac473503b14670b20b56ca29e0343a/Clift%2C%20Skingley%2C%20Dickinson%2C%20Meadows.pdf (added 15/08/2022) 2022 Results article in https://storage.googleapis.com/wzukusers/user-20563976/documents/caed00163dca4113aa72a0c60ca0369a/Price%2C%20Skingley.pdf Implementation and evaluation (added 15/08/2022) 2022 Results article in https://storage.googleapis.com/wzukusers/user-20563976/documents/e7c1aaf2e5214e0db98c08693d7f45fd/Lane%2C%20Cooke%2C%20Skingley.pdf Participant experiences (added 15/08/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-05-08
• Study Completion: 2020-03-31
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

The trial will be open to patients:
1. With a diagnosis of COPD who have received pulmonary rehabilitation (or in receipt during the recruitment period)
2. Willing to undergo the collection of assessments planned
3. Willing to be randomised to either the intervention or control group
4. Able to attend one of the two groups planned (given the proposed day and time)

Exclusion Criteria

1. Are unable to give informed consent
2. Have comorbid conditions that make participation difficult
3. Are unable to travel independently to the venues
4. Are not sufficiently fluent in English to complete the questionnaires employed

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life assessed with the COPD Assessment Test (CAT) at baseline, three months following the ten-week intervention, and then after a further three months.

Secondary Outcome Measures

Name	Time	Method
<br> Measured at baseline, three months following the ten-week intervention, and then after a further three months:<br> 1. Breathlessness assessed using mMRC self-completion questionnaire<br> 2. Physical health related quality of life and mental health related quality of life assessed using SF-36 v2 self-completion questionnaire<br> 3. Generalised anxiety disorder assessed by GAD-7 (self-completion questionnaire)<br> 4. Depression assessed by PHQ-9 (self-completion questionnaire)<br> 5. Lung function and patterns of breathing assessed by standardised spirometry and structured light plethysmography<br> 6. Functional exercise measured by the standardised six-minute walk test<br>